Maternal Health Outcomes in Complex Pregnancy Conditions

Complex pregnancy conditions such as pre-eclampsia, mirror syndrome, twin-to-twin transfusion syndrome and infection-mediated placental dysfunction impose profound challenges to maternal health. These disorders often arise from aberrant placental development, dysregulated angiogenesis and inflammatory cascades, leading to hypertension, oedema, proteinuria and multiorgan compromise. Maternal outcomes range from mild symptomatic burden to life-threatening complications including pulmonary oedema, renal impairment and coagulation disturbances. Innovative diagnostic biomarkers, refined imaging techniques and targeted intrauterine therapies have begun to reshape management, enabling earlier identification and intervention. Nevertheless, disparities in resource availability and variable access to specialised care continue to fuel global inequities in maternal morbidity and mortality. A holistic overview of current research underscores the importance of integrating molecular insights with clinical practice, advancing both prophylactic strategies and therapeutic pathways to safeguard maternal well-being in high-risk pregnancies worldwide.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Maternal Health Outcomes in Complex Pregnancy Conditions publication trend

The graph below shows the total number of articles in maternal health outcomes in complex pregnancy conditions across all publications each year (not limited to Nature Index journals).

Technical terms

Mirror syndrome (Ballantyne’s syndrome): Maternal condition characterised by maternal oedema and pre-eclampsia-like signs in association with fetal hydrops.

Twin-to-twin transfusion syndrome (TTTS): Complication of monochorionic twin pregnancies in which abnormal placental vascular anastomoses cause imbalanced blood flow between twins.

Fetal hydrops: Abnormal accumulation of fluid in fetal compartments, often due to cardiac, haematological, chromosomal or infectious aetiologies.

Angiogenic markers (PlGF and sFlt-1): Proteins regulating placental vascular growth; their imbalance is implicated in pre-eclampsia and in monitoring placental function.

Ischaemia-reperfusion injury: Tissue damage resulting from the restoration of blood flow after a period of hypoxia, contributing to placental dysfunction.

References

1. Molecular Mechanisms Underlying Twin-to-Twin Transfusion Syndrome. Cells (2022).
2. The role of fetal therapy in the management of mirror syndrome: a narrative review. The Journal of Maternal-Fetal & Neonatal Medicine (2024).
3. Clinical characteristics and risk factors of mirror syndrome: a retrospective case-control study. BMC Pregnancy and Childbirth (2021).